抑制血清和糖皮质激素调节蛋白激酶-1通过NF-kB通路加重咪喹莫特诱导的银屑病皮炎并增强促炎细胞因子表达
研究探讨SGK1在银屑病中的调控作用及机制。发现银屑病患者巨噬细胞中SGK1表达降低;SGK1抑制剂EMD638683增强RAW264.7细胞中咪喹莫特介导的TLR7/8活性和促炎细胞因子产生,经Sgk1 siRNA证实;机制上SGK1抑制增加BTK磷酸化,BTK抑制可消除该促炎效应;小鼠模型中SGK1抑制增加IL-1β、IL-6、TNF-α分泌及Th17细胞浸润。
要点
- 银屑病患者巨噬细胞中SGK1表达降低。
- SGK1抑制通过增加BTK磷酸化增强TLR7/8通路促炎效应。
- 咪喹莫特诱导银屑病小鼠模型中SGK1抑制加重炎症。
核心结论
- SGK1通过调节皮损炎症反应在银屑病发病中起关键作用,SGK1-BTK信号可能成为控制银屑病的新治疗靶点。
研究设计与样本
- 研究检测银屑病患者巨噬细胞中SGK1表达,并在RAW264.7细胞和小鼠模型中进行机制与体内验证。
主要发现
- 银屑病患者巨噬细胞中SGK1表达降低。
- SGK1抑制剂EMD638683显著增强RAW264.7细胞中咪喹莫特介导的TLR7/8活性和促炎细胞因子产生,Sgk1 siRNA证实该结果。
- SGK1抑制增加BTK磷酸化,BTK抑制消除了SGK1抑制剂对TLR7/8激活的促炎效应。
- 咪喹莫特诱导银屑病小鼠模型中SGK1抑制显著增加IL-1β、IL-6、TNF-α分泌及Th17细胞浸润。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although the anti-inflammatory effect of serum- and glucocorticoid-regulated protein kinase 1 (SGK1) has been established in other diseases, the possible regulatory role of SGK1 in psoriasis and the underlying molecular mechanisms remain largely unknown. In this study, we found that SGK1 expression was decreased in macrophages from patients with psoriasis. Moreover, a specific pharmacological SGK1 inhibitor, EMD638683, significantly enhanced imiquimod-mediated toll-like receptor 7/8 activity and proinflammatory cytokine production in RAW264.7 cells, and this result was confirmed by Sgk1 small interfering RNA. Further mechanistic data showed that SGK1 inhibition increased the phosphorylation of Bruton's agammaglobulinemia tyrosine kinase; moreover, Bruton's agammaglobulinemia tyrosine kinase inhibition abrogated the proinflammatory effects of the SGK1 inhibitor on toll-like receptor 7/8 activation, thereby validating that SGK1 inhibition enhances the toll-like receptor 7/8 pathway by increasing Bruton's agammaglobulinemia tyrosine kinase phosphorylation. In addition, our in vivo results showed that SGK1 inhibition significantly increased the secretion of proinflammatory cytokines, including IL-1β, IL-6, and TNF-α, and the infiltration of T helper 17 cells in an imiquimod-induced psoriasis mouse model. Altogether, these results show that SGK1 plays a critical role in the pathogenesis of psoriasis by modulating inflammatory responses in skin lesions, indicating that SGK1‒Bruton's agammaglobulinemia tyrosine kinase signaling could be a novel therapeutic target for the control of psoriasis.
引用
- Meng Q, Bai M, Guo M, et al. Inhibition of Serum- and Glucocorticoid-Regulated Protein Kinase-1 Aggravates Imiquimod-Induced Psoriatic Dermatitis and Enhances Proinflammatory Cytokine Expression through the NF-kB Pathway. J Invest Dermatol. 2023. PMID: 36623704. doi:10.1016/j.jid.2022.12.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。